Buy Sun Pharma; target of Rs 1220: Motilal Oswal
News2023-02-02
0 Views
Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1220 in its research report dated January 31, 2023.
Latest News from Moneycontrol.com
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
Breaking News: Bondezz™ Appoints Brian Colando as Vice President of Sales to Lead Wholesale Expansion
